Increased O-GlcNAcylation in Leukocytes from Overweight Pediatric Subjects: A Pilot Study

Area of Science:

• Biochemistry
• Pediatrics
• Metabolic Disorders

Background:

• Type II diabetes mellitus (T2D) is a significant metabolic disorder.
• Childhood overweight and obesity increase the risk of developing T2D later in life.
• Early identification of at-risk individuals is crucial for T2D prevention and management.

Purpose of the Study:

• To investigate if leukocyte protein O-GlcNAc modification is elevated in an overweight pediatric cohort.
• To explore leukocyte protein O-GlcNAcylation as a potential early biomarker for metabolic abnormalities.
• To assess the correlation between leukocyte protein O-GlcNAcylation and anthropometric/metabolic markers in children.

Main Methods:

• Recruitment of 16 children (8 overweight, 8 normal-weight) aged 3-13 years.
• Conducting physical exams and comprehensive blood tests.
• Determining leukocyte protein O-GlcNAcylation levels.

Main Results:

• Leukocyte protein O-GlcNAcylation was significantly higher in overweight children compared to normal-weight children.
• Elevated O-GlcNAcylation correlated with Body Mass Index (BMI), LDL-cholesterol, triglycerides, and CRP levels.
• These findings suggest a link between O-GlcNAcylation and metabolic/inflammatory status in pediatric obesity.

Conclusions:

• Leukocyte protein O-GlcNAcylation may serve as a novel biomarker for early detection of metabolic abnormalities in children.
• This biomarker could aid in identifying individuals at risk for pre-diabetes or T2D.
• Further research is warranted to validate these findings and explore therapeutic implications.